OS Therapies Inc — Form D

OS Therapies Inc of Grasonville, MD, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-06. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
John P. CiccioDirectorGrasonville, MD
Karim P. GalzahrDirectorGrasonville, MD
Olivier P. JarryDirectorGrasonville, MD
Avril P. McKean DieserDirectorGrasonville, MD
Paul A. RomnessDirectorGrasonville, MD
Theodore F. SearchDirectorGrasonville, MD
Christopher P. AcevedoExecutive OfficerGrasonville, MD
Robert G. PetitExecutive OfficerGrasonville, MD
Paul A. RomnessExecutive OfficerGrasonville, MD
Paul A RomnessDirectorGrasonville, MD
Paul A RomnessExecutive OfficerGrasonville, MD
Avril P McKean DieserDirectorGrasonville, MD
Christopher P AcevedoExecutive OfficerGrasonville, MD
Karim P GalzahrDirectorGrasonville, MD
Robert G PetitExecutive OfficerGrasonville, MD
John P CiccioDirectorGrasonville, MD
Olivier P JarryDirectorGrasonville, MD
Gerald P CommissiongExecutive OfficerGrasonville, MD
Olivier R JarryDirectorGrasonville, MD
Craig EagleRelated PersonGrasonville, MD
Colin P GoddardDirectorRockville, MD
Joacim P BorgDirectorRockville, MD
Joacim BorgDirectorRockville, MD
Colin GoddardDirectorJUPITER, FL
Jutta WannerExecutive OfficerRockville, MD

Other filings by this issuer (10)

FiledFormOfferingSold
2026-07-16D$9.3M$1.6M
2026-01-20D$7.5M$3.5M
2025-09-10D$3.8M$3.8M
2025-07-16D$4.2M$4.2M
2025-01-22D$10.0M$7.1M
2023-12-14D$2.0M$700K
2023-01-11D$2.0M$2.0M
2021-09-01D$5.0M$1.0M
2020-05-01D$5.0M
2019-12-05D$500K$359K

More